Fundz

Fluid Biomed Inc. raised $27 million in a Series A led by Amplitude Ventures to advance its bioabsorbable polymer-based stent for treating brain aneurysms.

PRIVATEDec 16, 2024

Amount Raised

$27 Million

Round Type

Series A

CalgaryBiotechnologyHealth CareMedicalMedical Device

Investors

LifeArc VenturesShangbay CapitalMetis InnovativeAmplitude VenturesIAG Capital Partners

Description

Fluid Biomed Inc. closed an oversubscribed $27 million Series A financing round to further validate its innovative stent technology. The round was co-led by Amplitude Ventures and a major strategic partner, with additional investments from several notable firms.

Quick answer

Fluid Biomed raised $27 Million in a Series A round, dated December 16, 2024. Investors: LifeArc Ventures, Shangbay Capital, Metis Innovative, Amplitude Ventures and IAG Capital Partners. Fluid Biomed is based in Calgary, Alberta, Canada.

How much did Fluid Biomed raise?
Fluid Biomed raised $27 Million in a Series A round on December 16, 2024.
Who invested in Fluid Biomed?
LifeArc Ventures, Shangbay Capital, Metis Innovative, Amplitude Ventures and IAG Capital Partners are named as investors in this round.
What does Fluid Biomed do?
Fluid Biomed is a medical device start-up founded by two neurosurgeons at the University of Calgary that has developed an implantable dissolving stent to divert blood flow and heal blood vessels.
Where is Fluid Biomed based and how big is it?
Fluid Biomed is based in Calgary, Alberta, Canada.
Who are the decision-makers at Fluid Biomed?
Fundz holds 1 contact at Fluid Biomed. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Fluid Biomed that raised within 45 days of this round, from Fundz verified event records.

  • Xaga Surgical raised $726K (Seed) on January 30, 2025.
  • Sycai Medical raised $3.1M (Seed) on January 23, 2025.
  • SVASTEK raised $231K (Seed) on January 23, 2025.
  • ErlySign raised $1.8M (Pre-Series A) on January 16, 2025.
  • Convergence Medical raised $5M (Series A) on January 16, 2025.
  • Core Sound Imaging raised $80M on January 16, 2025.

Who to call at Fluid Biomed, and when

A new round usually means Fluid Biomed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Fluid Biomed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fluid Biomed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fluid Biomed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fluid Biomed

Location

Calgary, Alberta, Canada

About

Fluid Biomed is a medical device start-up founded by two neurosurgeons at the University of Calgary that has developed an implantable dissolving stent to divert blood flow and heal blood vessels. The desire to innovate and create positive change has always been a priority for the founders and inventors, Dr. John Wong and Dr. Alim Mitha. Working together for the past 18 years to help people with stroke, their drive and commitment to improve patient health sparked a vision to create a radical new stent to cure brain aneurysms without invasive surgery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fluid Biomed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Fluid Biomed's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Fluid Biomed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.